CA2984644A1 - Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish - Google Patents
Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish Download PDFInfo
- Publication number
- CA2984644A1 CA2984644A1 CA2984644A CA2984644A CA2984644A1 CA 2984644 A1 CA2984644 A1 CA 2984644A1 CA 2984644 A CA2984644 A CA 2984644A CA 2984644 A CA2984644 A CA 2984644A CA 2984644 A1 CA2984644 A1 CA 2984644A1
- Authority
- CA
- Canada
- Prior art keywords
- egg
- agent
- guanidine
- eggs
- fish
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 119
- 241001465754 Metazoa Species 0.000 title claims abstract description 113
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 102
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 95
- 238000002723 toxicity assay Methods 0.000 title claims description 7
- 235000013601 eggs Nutrition 0.000 title abstract description 221
- 238000004519 manufacturing process Methods 0.000 title abstract description 17
- 210000002257 embryonic structure Anatomy 0.000 title description 31
- 208000021267 infertility disease Diseases 0.000 title description 16
- 238000007877 drug screening Methods 0.000 title description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims abstract description 151
- 150000001875 compounds Chemical class 0.000 claims abstract description 79
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims abstract description 75
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims abstract description 75
- 210000001136 chorion Anatomy 0.000 claims abstract description 54
- 238000007654 immersion Methods 0.000 claims abstract description 46
- 230000035699 permeability Effects 0.000 claims abstract description 37
- 238000011161 development Methods 0.000 claims abstract description 30
- 230000002710 gonadal effect Effects 0.000 claims abstract description 28
- 210000004681 ovum Anatomy 0.000 claims abstract description 25
- 230000004720 fertilization Effects 0.000 claims abstract description 14
- 238000007878 drug screening assay Methods 0.000 claims abstract description 3
- 235000019688 fish Nutrition 0.000 claims description 97
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 61
- 230000000692 anti-sense effect Effects 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 241000277331 Salmonidae Species 0.000 claims description 34
- 241000252212 Danio rerio Species 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 230000014509 gene expression Effects 0.000 claims description 16
- 101150100366 end gene Proteins 0.000 claims description 14
- 239000004475 Arginine Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 230000004913 activation Effects 0.000 claims description 12
- 241000277263 Salmo Species 0.000 claims description 10
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 9
- 241000277275 Oncorhynchus mykiss Species 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 230000004044 response Effects 0.000 claims description 7
- 241000276616 Cichlidae Species 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 231100000167 toxic agent Toxicity 0.000 claims description 6
- 239000003440 toxic substance Substances 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 239000000539 dimer Substances 0.000 claims description 5
- 229940000406 drug candidate Drugs 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 239000013638 trimer Substances 0.000 claims description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
- 241000972773 Aulopiformes Species 0.000 claims description 4
- 101100263436 Drosophila melanogaster vas gene Proteins 0.000 claims description 4
- 108010060374 FSH Receptors Proteins 0.000 claims description 4
- 102000008238 LHRH Receptors Human genes 0.000 claims description 4
- 108010021290 LHRH Receptors Proteins 0.000 claims description 4
- 241000549556 Nanos Species 0.000 claims description 4
- 101100049051 Penaeus vannamei vasa gene Proteins 0.000 claims description 4
- 241000269799 Perca fluviatilis Species 0.000 claims description 4
- 241001519451 Abramis brama Species 0.000 claims description 3
- 241000473391 Archosargus rhomboidalis Species 0.000 claims description 3
- 241000238424 Crustacea Species 0.000 claims description 3
- 241000252233 Cyprinus carpio Species 0.000 claims description 3
- 241000264060 Lethrinus Species 0.000 claims description 3
- 241000237852 Mollusca Species 0.000 claims description 3
- 241000202240 Morone americana Species 0.000 claims description 3
- 241000277326 Oncorhynchus gorbuscha Species 0.000 claims description 3
- 241000277329 Oncorhynchus keta Species 0.000 claims description 3
- 241000277338 Oncorhynchus kisutch Species 0.000 claims description 3
- 241000277269 Oncorhynchus masou Species 0.000 claims description 3
- 241000277277 Oncorhynchus nerka Species 0.000 claims description 3
- 241001280377 Oncorhynchus tshawytscha Species 0.000 claims description 3
- 241000269798 Perca flavescens Species 0.000 claims description 3
- 241000277288 Salmo trutta Species 0.000 claims description 3
- 241000277293 Salvelinus alpinus Species 0.000 claims description 3
- 241000277284 Salvelinus fontinalis Species 0.000 claims description 3
- 241001220177 Thymallus arcticus Species 0.000 claims description 3
- 241000276707 Tilapia Species 0.000 claims description 3
- 241001233037 catfish Species 0.000 claims description 3
- 235000019515 salmon Nutrition 0.000 claims description 3
- 238000001890 transfection Methods 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 claims description 2
- 241001125776 Melanochromis auratus Species 0.000 claims description 2
- 241000202236 Morone chrysops Species 0.000 claims description 2
- 241000202238 Morone mississippiensis Species 0.000 claims description 2
- 241001481825 Morone saxatilis Species 0.000 claims description 2
- 241000143387 Moronidae Species 0.000 claims description 2
- 241000276701 Oreochromis mossambicus Species 0.000 claims description 2
- 241000276703 Oreochromis niloticus Species 0.000 claims description 2
- 241001489531 Thymallus thymallus Species 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 241000894007 species Species 0.000 abstract description 12
- 230000002708 enhancing effect Effects 0.000 abstract description 11
- 238000009360 aquaculture Methods 0.000 abstract description 8
- 244000144974 aquaculture Species 0.000 abstract description 8
- 230000000270 postfertilization Effects 0.000 abstract description 3
- 238000003611 compound toxicity assay Methods 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 27
- 230000018109 developmental process Effects 0.000 description 26
- 108010011110 polyarginine Proteins 0.000 description 19
- 239000000412 dendrimer Substances 0.000 description 17
- 229920000736 dendritic polymer Polymers 0.000 description 17
- 210000001161 mammalian embryo Anatomy 0.000 description 17
- 210000002149 gonad Anatomy 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- 229920002307 Dextran Polymers 0.000 description 14
- 210000004602 germ cell Anatomy 0.000 description 13
- 239000012867 bioactive agent Substances 0.000 description 12
- 238000011534 incubation Methods 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 10
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 9
- -1 dendrimers Chemical compound 0.000 description 9
- 238000013508 migration Methods 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 230000026109 gonad development Effects 0.000 description 8
- 230000005012 migration Effects 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 238000003822 preparative gas chromatography Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 6
- 230000002611 ovarian Effects 0.000 description 6
- 210000001672 ovary Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 210000001550 testis Anatomy 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 230000011712 cell development Effects 0.000 description 5
- 208000000509 infertility Diseases 0.000 description 5
- 230000036512 infertility Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 150000002605 large molecules Chemical class 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000008175 FSH Receptors Human genes 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 150000001483 arginine derivatives Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000013505 freshwater Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 231100000503 infertility induction Toxicity 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 108010039627 Aprotinin Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 2
- 229910006069 SO3H Inorganic materials 0.000 description 2
- 229960004405 aprotinin Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 150000002357 guanidines Chemical class 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 2
- 108010052968 leupeptin Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000037257 muscle growth Effects 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 241000238017 Astacoidea Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000269800 Percidae Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- VQNVZLDDLJBKNS-UHFFFAOYSA-N carbamimidoylazanium;bromide Chemical class Br.NC(N)=N VQNVZLDDLJBKNS-UHFFFAOYSA-N 0.000 description 1
- STIAPHVBRDNOAJ-UHFFFAOYSA-N carbamimidoylazanium;carbonate Chemical compound NC(N)=N.NC(N)=N.OC(O)=O STIAPHVBRDNOAJ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- KMSRVXJGTIRNNK-UHFFFAOYSA-N diaminomethylideneazanium;hydrogen carbonate Chemical class NC(N)=N.OC(O)=O KMSRVXJGTIRNNK-UHFFFAOYSA-N 0.000 description 1
- ZZTURJAZCMUWEP-UHFFFAOYSA-N diaminomethylideneazanium;hydrogen sulfate Chemical compound NC(N)=N.OS(O)(=O)=O ZZTURJAZCMUWEP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 101150049432 dnd gene Proteins 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 230000018853 germ cell migration Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- DXTIKTAIYCJTII-UHFFFAOYSA-N guanidine acetate Chemical compound CC([O-])=O.NC([NH3+])=N DXTIKTAIYCJTII-UHFFFAOYSA-N 0.000 description 1
- NDEMNVPZDAFUKN-UHFFFAOYSA-N guanidine;nitric acid Chemical compound NC(N)=N.O[N+]([O-])=O.O[N+]([O-])=O NDEMNVPZDAFUKN-UHFFFAOYSA-N 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/20—Animals treated with compounds which are neither proteins nor nucleic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/40—Fish
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3233—Morpholino-type ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/40—Monitoring or fighting invasive species
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Farming Of Fish And Shellfish (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562163511P | 2015-05-19 | 2015-05-19 | |
| US62/163,511 | 2015-05-19 | ||
| US201662274958P | 2016-01-05 | 2016-01-05 | |
| US62/274,958 | 2016-01-05 | ||
| PCT/US2016/032873 WO2016187198A2 (en) | 2015-05-19 | 2016-05-17 | Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2984644A1 true CA2984644A1 (en) | 2016-11-24 |
Family
ID=56084421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2984644A Pending CA2984644A1 (en) | 2015-05-19 | 2016-05-17 | Methods of agent delivery into eggs and embryos of egg-producing aquatic animals for drug screening, agent toxicity assay and production of infertile fish |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10709119B2 (enExample) |
| EP (1) | EP3297429A2 (enExample) |
| JP (1) | JP6756960B2 (enExample) |
| CN (1) | CN108040459B (enExample) |
| AU (1) | AU2016265929B2 (enExample) |
| BR (1) | BR112017024662A2 (enExample) |
| CA (1) | CA2984644A1 (enExample) |
| CL (1) | CL2017002864A1 (enExample) |
| DK (1) | DK180094B1 (enExample) |
| IL (1) | IL255338B (enExample) |
| MX (1) | MX386910B (enExample) |
| RU (1) | RU2741645C2 (enExample) |
| WO (1) | WO2016187198A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015073819A1 (en) | 2013-11-15 | 2015-05-21 | University Of Maryland Baltimore County | Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos |
| PL3723479T3 (pl) * | 2017-12-15 | 2024-10-07 | Acd Pharmaceuticals As | Sposoby produkcji sterylnych ryb |
| WO2020125848A1 (de) * | 2018-12-17 | 2020-06-25 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung | Verfahren, das der herstellung von kaviar oder einem kaviarähnlichem produkt aus lebenden, reifen eiern von fischen oder krebstieren dient, und solche produkte |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115794B2 (en) * | 2003-05-19 | 2006-10-03 | University Of Hawaii | Method for direct nucleic acid uptake |
| US7194978B2 (en) | 2003-08-22 | 2007-03-27 | University Of Maryland Biotechnology Institute | Inducing sterility in fish by disrupting the development of the GnRH system |
| CN1294808C (zh) | 2003-09-26 | 2007-01-17 | 中国科学院水生生物研究所 | 不育转基因鱼的制备方法 |
| CN1274822C (zh) | 2004-02-19 | 2006-09-13 | 武汉康祥科技发展有限公司 | 活体化学诱导鱼类雌核发育方法 |
| CN101553210A (zh) * | 2006-09-20 | 2009-10-07 | 奈克斯特安全有限公司 | 经吸入输送药物的方法和系统 |
| CN103898161A (zh) | 2007-01-26 | 2014-07-02 | 辛那杰瓦生物制药股份有限公司 | 在禽类中进行转基因表达 |
| US7935816B2 (en) | 2007-10-25 | 2011-05-03 | Gene Tools, Llc | Molecular transporter compositions comprising dendrimeric oligoguanidine with a triazine core that facilitate delivery into cells in vivo |
| US8383880B2 (en) | 2009-02-18 | 2013-02-26 | Academia Sinica | Infertility control of genetically modified fish |
| WO2011018798A2 (en) * | 2009-08-14 | 2011-02-17 | Indian Association For The Cultivation Of Science | Morpholino-based antisense agent |
| CA2789454A1 (en) | 2010-02-09 | 2011-08-18 | National University Corporation Hokkaido University | Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera |
| CA2825994A1 (en) | 2011-02-01 | 2012-08-09 | Ten-Tsao WONG | Efficient sterilization of fish by disruption of germ cell development |
| GB201117538D0 (en) * | 2011-10-11 | 2011-11-23 | Royal Veterinary College The | Methods |
| RU2504389C2 (ru) * | 2012-02-16 | 2014-01-20 | Федеральное государственное бюджетное учреждение науки Институт биохимии и физиологии микроорганизмов им. Г.К. Скрябина Российской академии наук (ИБФМ РАН) | СПОСОБ ПОРОФОРМИРОВАНИЯ В МЕМБРАНАХ КЛЕТОК ПЕЧЕНИ С ПОМОЩЬЮ ОБРАБОТКИ ИХ ГЕМОЛИЗИНОМ II Bacillus cereus |
| US9538734B2 (en) | 2013-03-12 | 2017-01-10 | The General Hospital Corporation | Germ cell ablation compounds and uses thereof |
| WO2015073819A1 (en) * | 2013-11-15 | 2015-05-21 | University Of Maryland Baltimore County | Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos |
-
2016
- 2016-05-17 RU RU2017142635A patent/RU2741645C2/ru active
- 2016-05-17 CN CN201680028215.1A patent/CN108040459B/zh active Active
- 2016-05-17 US US15/568,729 patent/US10709119B2/en active Active
- 2016-05-17 WO PCT/US2016/032873 patent/WO2016187198A2/en not_active Ceased
- 2016-05-17 CA CA2984644A patent/CA2984644A1/en active Pending
- 2016-05-17 JP JP2017559661A patent/JP6756960B2/ja active Active
- 2016-05-17 EP EP16725715.3A patent/EP3297429A2/en active Pending
- 2016-05-17 DK DKPA201770877A patent/DK180094B1/en active IP Right Grant
- 2016-05-17 BR BR112017024662A patent/BR112017024662A2/pt not_active Application Discontinuation
- 2016-05-17 MX MX2017014856A patent/MX386910B/es unknown
- 2016-05-17 AU AU2016265929A patent/AU2016265929B2/en active Active
-
2017
- 2017-10-30 IL IL255338A patent/IL255338B/en unknown
- 2017-11-10 CL CL2017002864A patent/CL2017002864A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2741645C2 (ru) | 2021-01-28 |
| US20180295817A1 (en) | 2018-10-18 |
| CL2017002864A1 (es) | 2018-05-18 |
| MX2017014856A (es) | 2018-04-20 |
| DK180094B1 (en) | 2020-04-27 |
| AU2016265929A1 (en) | 2017-11-09 |
| DK201770877A1 (en) | 2017-11-27 |
| RU2017142635A3 (enExample) | 2019-12-16 |
| NZ737306A (en) | 2025-02-28 |
| CN108040459B (zh) | 2021-09-21 |
| JP6756960B2 (ja) | 2020-09-16 |
| MX386910B (es) | 2025-03-19 |
| JP2018515116A (ja) | 2018-06-14 |
| AU2016265929B2 (en) | 2022-03-31 |
| BR112017024662A2 (pt) | 2018-09-11 |
| WO2016187198A3 (en) | 2017-01-12 |
| IL255338B (en) | 2022-05-01 |
| WO2016187198A2 (en) | 2016-11-24 |
| EP3297429A2 (en) | 2018-03-28 |
| US10709119B2 (en) | 2020-07-14 |
| CN108040459A (zh) | 2018-05-15 |
| IL255338A0 (en) | 2017-12-31 |
| RU2017142635A (ru) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10136621B2 (en) | Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos | |
| Hattori et al. | Surrogate production of Salmo salar oocytes and sperm in triploid Oncorhynchus mykiss by germ cell transplantation technology | |
| AU2016265929B2 (en) | Methods of agent delivery into eggs of egg-producing aquatic animals | |
| Pavlov et al. | Bacterial destruction of the egg shell of common wolffish during incubation | |
| Aruho et al. | Morphology and functional ontogeny of the digestive tract of Barbus altianali s larvae | |
| Carvalho et al. | Embryo manipulation in neotropical characiform fish: incubation system, anaesthetic, and PGC transplantation in Prochilodus lineatus | |
| AU2018385901B2 (en) | Methods for the production of sterile fish and other egg-producing aquatic animals and compounds for use in the methods | |
| BR112016011080B1 (pt) | Método para a produção de peixe reprodutivamente estéril e composição para tratamento de ovo(s) de peixe para gerar peixe produzido a partir do(s) mesmo(s), reprodutivamente estéril | |
| Linhartová et al. | Crispr-Cas13d Mediated Germ Cell Ablation in Sterlet Sturgeon: Advancing Surrogate Reproduction Technologies for Endangered Species | |
| NZ737306B2 (en) | Methods of agent delivery into eggs of egg-producing aquatic animals | |
| Hotel et al. | The Sixth Japan-Korea, Korea-Japan Joint Symposium on Aquaculture | |
| ÖZDEMİR et al. | ORAL PRESENTATION | |
| Bar | Developing Spermatogonial Germ Cell Transplantation Technology for the Production of Southern Bluefin Tuna (Thunnus maccoyii) Seed-Producing Surrogates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |
|
| EEER | Examination request |
Effective date: 20210511 |